This study has 2 arms: the standard care group followed the COVID-19 guidelines of the Ministry of Health of Vietnam and the interventional group: Fluticasone propionate MDI with spacer, twice a day for 14 days.
The study participants will be monitored via video call from day 1 to day 14, day 21, and day 28 after randomized.
